STRATA Skin Sciences, Inc. (SSKN)
USD 3.0
(-1.64%)
USD 3.0
(-1.64%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 29.32 Million USD | -3.66% |
| 2022 | 30.44 Million USD | 43.73% |
| 2021 | 21.17 Million USD | 1.4% |
| 2020 | 20.88 Million USD | 11.75% |
| 2019 | 18.69 Million USD | 14.95% |
| 2018 | 16.25 Million USD | -0.78% |
| 2017 | 16.38 Million USD | -42.45% |
| 2016 | 28.47 Million USD | -19.3% |
| 2015 | 35.28 Million USD | 352.72% |
| 2014 | 7.79 Million USD | 33.55% |
| 2013 | 5.83 Million USD | 77.14% |
| 2012 | 3.29 Million USD | 107.74% |
| 2011 | 1.58 Million USD | -11.42% |
| 2010 | 1.79 Million USD | -1.15% |
| 2009 | 1.81 Million USD | 18.36% |
| 2008 | 1.53 Million USD | 14.5% |
| 2007 | 1.33 Million USD | 15.03% |
| 2006 | 1.16 Million USD | 26.78% |
| 2005 | 916.34 Thousand USD | -91.39% |
| 2004 | 10.64 Million USD | 1537.88% |
| 2003 | 650 Thousand USD | -87.0% |
| 2002 | 5 Million USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 30.08 Million USD | -1.73% |
| 2024 Q1 | 30.61 Million USD | 4.39% |
| 2023 FY | 29.32 Million USD | -3.66% |
| 2023 Q1 | 29.8 Million USD | -2.1% |
| 2023 Q3 | 31 Million USD | -19.05% |
| 2023 Q2 | 38.29 Million USD | 28.5% |
| 2023 Q4 | 29.32 Million USD | -5.39% |
| 2022 Q4 | 30.44 Million USD | -3.16% |
| 2022 Q3 | 31.43 Million USD | 0.6% |
| 2022 FY | 30.44 Million USD | 43.73% |
| 2022 Q1 | 31.3 Million USD | 47.82% |
| 2022 Q2 | 31.24 Million USD | -0.19% |
| 2021 Q4 | 21.17 Million USD | 2.94% |
| 2021 Q1 | 21.71 Million USD | 3.98% |
| 2021 Q2 | 19.1 Million USD | -12.05% |
| 2021 Q3 | 20.57 Million USD | 7.72% |
| 2021 FY | 21.17 Million USD | 1.4% |
| 2020 Q4 | 20.88 Million USD | -1.19% |
| 2020 Q3 | 21.13 Million USD | 8.77% |
| 2020 Q2 | 19.43 Million USD | 7.96% |
| 2020 Q1 | 17.99 Million USD | -3.7% |
| 2020 FY | 20.88 Million USD | 11.75% |
| 2019 Q1 | 17.5 Million USD | 7.64% |
| 2019 Q3 | 18.66 Million USD | 0.83% |
| 2019 Q4 | 18.69 Million USD | 0.16% |
| 2019 FY | 18.69 Million USD | 14.95% |
| 2019 Q2 | 18.5 Million USD | 5.75% |
| 2018 Q2 | 12.35 Million USD | -27.12% |
| 2018 Q1 | 16.94 Million USD | 3.43% |
| 2018 Q4 | 16.25 Million USD | 26.89% |
| 2018 FY | 16.25 Million USD | -0.78% |
| 2018 Q3 | 12.81 Million USD | 3.73% |
| 2017 FY | 16.38 Million USD | -42.45% |
| 2017 Q1 | 30.61 Million USD | 7.52% |
| 2017 Q2 | 31.28 Million USD | 2.2% |
| 2017 Q3 | 15.94 Million USD | -49.03% |
| 2017 Q4 | 16.38 Million USD | 2.75% |
| 2016 FY | 28.47 Million USD | -19.3% |
| 2016 Q4 | 28.47 Million USD | 5.17% |
| 2016 Q3 | 27.07 Million USD | -0.22% |
| 2016 Q2 | 27.13 Million USD | -16.45% |
| 2016 Q1 | 32.47 Million USD | -7.96% |
| 2015 Q4 | 35.28 Million USD | -2.74% |
| 2015 Q3 | 36.27 Million USD | 33.58% |
| 2015 Q2 | 27.15 Million USD | 212.93% |
| 2015 Q1 | 8.67 Million USD | 11.35% |
| 2015 FY | 35.28 Million USD | 352.72% |
| 2014 Q2 | 5.34 Million USD | -51.37% |
| 2014 Q4 | 7.79 Million USD | -14.25% |
| 2014 Q3 | 9.08 Million USD | 69.93% |
| 2014 FY | 7.79 Million USD | 33.55% |
| 2014 Q1 | 10.99 Million USD | 88.46% |
| 2013 Q2 | 9.06 Million USD | 7.87% |
| 2013 FY | 5.83 Million USD | 77.14% |
| 2013 Q4 | 5.83 Million USD | 104.06% |
| 2013 Q3 | 2.85 Million USD | -68.45% |
| 2013 Q1 | 8.4 Million USD | 155.07% |
| 2012 Q4 | 3.29 Million USD | 28.4% |
| 2012 Q2 | 2.57 Million USD | 52.18% |
| 2012 FY | 3.29 Million USD | 107.74% |
| 2012 Q3 | 2.56 Million USD | -0.46% |
| 2012 Q1 | 1.69 Million USD | 6.8% |
| 2011 Q2 | 1.38 Million USD | -22.36% |
| 2011 Q4 | 1.58 Million USD | 9.54% |
| 2011 Q3 | 1.44 Million USD | 4.38% |
| 2011 FY | 1.58 Million USD | -11.42% |
| 2011 Q1 | 1.78 Million USD | -0.21% |
| 2010 Q4 | 1.79 Million USD | -4.97% |
| 2010 FY | 1.79 Million USD | -1.15% |
| 2010 Q3 | 1.88 Million USD | 8.89% |
| 2010 Q2 | 1.73 Million USD | 5.31% |
| 2010 Q1 | 1.64 Million USD | -9.29% |
| 2009 Q3 | 1.52 Million USD | 14.33% |
| 2009 FY | 1.81 Million USD | 18.36% |
| 2009 Q4 | 1.81 Million USD | 18.72% |
| 2009 Q1 | 1.43 Million USD | -6.38% |
| 2009 Q2 | 1.33 Million USD | -6.85% |
| 2008 Q3 | 1.95 Million USD | -0.45% |
| 2008 Q2 | 1.96 Million USD | 13.1% |
| 2008 Q1 | 1.73 Million USD | 30.09% |
| 2008 FY | 1.53 Million USD | 14.5% |
| 2008 Q4 | 1.53 Million USD | -21.83% |
| 2007 Q4 | 1.33 Million USD | 42.36% |
| 2007 Q2 | 910.74 Thousand USD | -13.78% |
| 2007 Q1 | 1.05 Million USD | -9.08% |
| 2007 Q3 | 938.76 Thousand USD | 3.08% |
| 2007 FY | 1.33 Million USD | 15.03% |
| 2006 FY | 1.16 Million USD | 26.78% |
| 2006 Q4 | 1.16 Million USD | 68.45% |
| 2006 Q3 | 689.68 Thousand USD | -24.93% |
| 2006 Q2 | 918.78 Thousand USD | -11.69% |
| 2006 Q1 | 1.04 Million USD | 13.54% |
| 2005 FY | 916.34 Thousand USD | -91.39% |
| 2005 Q3 | 12.24 Million USD | 3.34% |
| 2005 Q4 | 916.34 Thousand USD | -92.52% |
| 2005 Q2 | 11.84 Million USD | 0.0% |
| 2004 FY | 10.64 Million USD | 1537.88% |
| 2004 Q4 | 10.64 Million USD | 0.0% |
| 2003 FY | 650 Thousand USD | -87.0% |
| 2002 FY | 5 Million USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acutus Medical, Inc. | 54.83 Million USD | 46.52% |
| Axonics, Inc. | 82.35 Million USD | 64.39% |
| INVO Bioscience, Inc. | 19.99 Million USD | -46.677% |
| CVRx, Inc. | 39.28 Million USD | 25.34% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 86.851% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -821.701% |
| MaxCyte, Inc. | 36.1 Million USD | 18.775% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -36.485% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 76.342% |
| Sintx Technologies, Inc. | 6.59 Million USD | -344.835% |
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 42.779% |
| Apyx Medical Corporation | 52.31 Million USD | 43.943% |
| Cutera, Inc. | 518.12 Million USD | 94.34% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -449.008% |
| NeuroPace, Inc. | 86.99 Million USD | 66.288% |
| IRIDEX Corporation | 24.91 Million USD | -17.717% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 66.595% |
| enVVeno Medical Corporation | 2.43 Million USD | -1104.435% |
| TELA Bio, Inc. | 59.16 Million USD | 50.432% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 95.411% |
| UFP Technologies, Inc. | 118.04 Million USD | 75.155% |
| Modular Medical, Inc. | 2.27 Million USD | -1190.845% |
| LENSAR, Inc. | 22.4 Million USD | -30.876% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 98.663% |
| Surmodics, Inc. | 65.82 Million USD | 55.444% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -184.214% |
| Inogen, Inc. | 121.38 Million USD | 75.838% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -1651.971% |
| RxSight, Inc. | 22.18 Million USD | -32.18% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -6796.146% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 0.855% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -26.774% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -6796.146% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -1107.261% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 71.963% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 95.831% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -15.179% |
| Dynatronics Corporation | 11.78 Million USD | -148.962% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 43.232% |
| InMode Ltd. | 75.91 Million USD | 61.367% |
| Bruker Corporation | 2.83 Billion USD | 98.966% |
| Movano Inc. | 5.97 Million USD | -391.092% |
| Orthofix Medical Inc. | 326.58 Million USD | 91.02% |
| FONAR Corporation | 57.45 Million USD | 48.957% |
| BioSig Technologies, Inc. | 4.68 Million USD | -525.998% |
| Envoy Medical, Inc. | 9.4 Million USD | -211.934% |
| Align Technology, Inc. | 2.45 Billion USD | 98.805% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 49.752% |
| Talis Biomedical Corporation | 29.22 Million USD | -0.356% |
| Cerus Corporation | 144.3 Million USD | 79.676% |
| 908 Devices Inc. | 37.49 Million USD | 21.771% |
| Nemaura Medical Inc. | 26.37 Million USD | -11.186% |
| Outset Medical, Inc. | 190.91 Million USD | 84.638% |
| NanoVibronix, Inc. | 2.68 Million USD | -991.884% |
| Venus Concept Inc. | 107.1 Million USD | 72.617% |
| Telesis Bio, Inc. | 40.87 Million USD | 28.246% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 74.267% |
| Quipt Home Medical Corp. | 136.29 Million USD | 78.482% |
| IRadimed Corporation | 20.73 Million USD | -41.436% |
| Tenon Medical, Inc. | 5.56 Million USD | -426.819% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -721.053% |
| Pulmonx Corporation | 60.63 Million USD | 51.633% |
| iCAD, Inc. | 8 Million USD | -266.554% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -131.102% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -1487.09% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 28.1% |
| SI-BONE, Inc. | 61.05 Million USD | 51.961% |
| Semler Scientific, Inc. | 6.27 Million USD | -367.751% |
| Biotricity, Inc. | 35.91 Million USD | 18.351% |
| Cytosorbents Corporation | 29.98 Million USD | 2.193% |
| DexCom, Inc. | 4.19 Billion USD | 99.301% |
| ZimVie Inc. | 795.85 Million USD | 96.315% |
| Aethlon Medical, Inc. | 2.47 Million USD | -1082.748% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -145.257% |
| IceCure Medical Ltd | 4.24 Million USD | -590.558% |
| PAVmed Inc | 57.13 Million USD | 48.671% |
| Sight Sciences, Inc. | 46.43 Million USD | 36.842% |
| Insulet Corporation | 1.85 Billion USD | 98.419% |
| Profound Medical Corp. | 12.66 Million USD | -131.552% |
| electroCore, Inc. | 8.94 Million USD | -227.87% |
| Bioventus Inc. | 589.79 Million USD | 95.027% |
| InspireMD, Inc. | 8.14 Million USD | -260.206% |
| PAVmed Inc. | 57.13 Million USD | 48.671% |
| Nuwellis, Inc. | 6.78 Million USD | -332.566% |
| OrthoPediatrics Corp. | 72.56 Million USD | 59.582% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -145.257% |
| BrainsWay Ltd. | 15.31 Million USD | -91.511% |
| BIOLASE, Inc. | 35.34 Million USD | 17.031% |
| Beyond Air, Inc. | 29.77 Million USD | 1.501% |
| AxoGen, Inc. | 101.16 Million USD | 71.009% |
| Inari Medical, Inc. | 209.32 Million USD | 85.989% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -1241.744% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -1548.567% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.07% |
| Quanterix Corporation | 78.08 Million USD | 62.44% |
| Viveve Medical, Inc. | 10.84 Million USD | -170.379% |
| LivaNova PLC | 1.15 Billion USD | 97.454% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -66.314% |
| Varex Imaging Corporation | 668.6 Million USD | 95.614% |
| Vivani Medical, Inc. | 25.03 Million USD | -17.143% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -621.654% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -721.053% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -500.368% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 97.193% |
| TransMedics Group, Inc. | 568.84 Million USD | 94.844% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -75.806% |
| NeuroMetrix, Inc. | 1.33 Million USD | -2099.945% |
| Spectral AI, Inc. | 12.4 Million USD | -136.497% |
| Hyperfine, Inc. | 9.8 Million USD | -199.265% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 88.28% |
| Biomerica, Inc. | 2.66 Million USD | -1001.314% |
| Bone Biologics Corporation | 831.4 Thousand USD | -3427.535% |
| AVITA Medical, Inc. | 19.86 Million USD | -47.634% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -1385.953% |
| Silk Road Medical, Inc | 114.15 Million USD | 74.309% |